sirtris

Sirtris Pharmaceuticals, Inc.
Sirtris Pharmaceuticals™ (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule www.sirtrispharma.com/ - 17k - Cached - Similar pages

Sirtris Pharmaceuticals: Resveratrol reduces fat and boosts
Nov 16, 2006 CAMBRIDGE, MA – March 1st, 2007 - Sirtris Pharmaceuticals Inc. today announced that it has filed a registration statement with the

A Few Additional Sirtris Links
Nov 5, 2006 I thought I'd point out a couple of links of interest to those following the recent burst of news on resveratrol and the efforts of Sirtris

News results for sirtris


Sirtris Tests Fountain of Youth Pill - Science Column - David
Nov 7, 2007 When Spanish explorer Juan Ponce de Leon heard rumors of a fountain of youth from native Floridians in 1513, he was desperate enough to find

Top Company Profiles - Sirtris Pharmaceuticals, Incorporated


Sirtris drug may fight diseases of age - The Boston Globe
Nov 29, 2007 Scientists at Sirtris Pharmaceuticals Inc. say they have created a drug that mimics the ingredient in red wine linked to longevity and the cell structures

Sirtris - Investor Relations - Overview
Sirtris Pharmaceuticals at BioCentury Publications Inc./Thomson Financial: Future Leaders in the Biotech Industry Conference (Replay)

Sirtris and Harvard Unveil Promising, Novel SIRT1 Activators for
Nov 28, 2007 Sirtris and Harvard Unveil Promising, Novel SIRT1 Activators for Treating Diseases of Aging; Therapeutic Type 2 Diabetes Data Published in

Sirtris unveils promising, novel SIRT1 activators for treating
Nov 28, 2007 Sirtris Pharmaceuticals Inc., a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of

Sirtris Pharmaceuticals' SRT501 Slows Retinal Ganglion Cell Loss
Mar 6, 2008 Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to

Sirtris Pharmaceuticals Presents at American Chemical Society April 7
(BUSINESS WIRE)--Apr 1, 2008 - Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced that

Barbara Walters to Feature Sirtris
Cambridge-based Sirtris Pharmaceuticals says researchers from the company will be featured Tuesday night in a Barbara Walters ABC television special entitled “Live to Be 150: Can You Do It?” As the narrator in a promo video for the

Sirtris Pharmaceuticals Presents At Future Leaders In The
Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced that it will be presenting at the

Sirtris Pharmaceuticals’ SRT501 Slows Retinal Ganglion Cell Loss
Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced that Kenneth Shindler, MD, PhD, University of Pennsylvania Scheie

GreenFuel Strikes A Deal, Sirtris Teams with Bayer on Crops
A new IPO filing, a few solid venture financings, and a decent assortment of new partnerships… Dare we call it an uptick it dealmaking? You be the judge. —GreenFuel Technologies, a Cambridge, MA firm developing algae-based

Sirtris Pharmaceuticals Inc.(SIRT) Technical analysis
Today we'll analyze the Stock sirt for online market trading, Technical indicators to notice: 1- Last bullish trend was from 11.02$ (02/22/08) to 11.94$ (02/29/08) a 0.92$ move 2- The current bearish trend started from 11.94$ at

Sirtris' SIRT1 Activators; Patent Covers First NCE to Enter Human
March 19, 2008--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced that the United States

Sirtris Pharmaceuticals Enters Collaborative Study Testing New
Sirtris Pharmaceuticals (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced that it will collaborate with the National Cancer Institute to test the

Sirtris Expands Revenue Potential into Agriculture
Capitalizing on its vast platform of life extending technologies, Sirtris announced today that it has expanded its scope into the agriculture industry by granting an exclusive license agreement to the crop science subsidiary of

Sirtris Pharmaceuticals Inc.
Another hot stock is Sirtris Pharmaceuticals. The startup’s activity is discovering and developing proprietary, orally available, small molecule drugs with the potential to treat metabolic diseases such as Type 2 Diabetes and such of

Sirtris Pharmaceuticals, Inc.
are in Cambridge, Massachusetts. To contact Sirtris click here Copyright © 2007, Sirtris Pharmaceuticals, Inc. ¤ Terms Of Use ¤ Privacy Statement Login

Sirtris Pharmaceuticals: Resveratrol reduces fat and boosts endurance
Press Releases CAMBRIDGE, MA – March 1st, 2007 - Sirtris Pharmaceuticals Inc. In addition, Sirtris has a robust pipeline of novel small molecule drug

BIOMOL International, LP - Biomolecules for Research Success
BIOMOL provides a unique and innovative combination of products and services to Blue-green algae-derived peptide triggers apoptosis " Brain Awareness Week

Technology Review: Blogs: David Ewing Duncan's blog: Longevity Pill
From MIT. Information on Emerging Technologies & impact on business & society company making the pill, Sirtris Pharmaceuticals, announced its findings from

A Few Additional Sirtris Links
recent burst of news on resveratrol and the efforts of Sirtris Pharmaceuticals. David Sinclair (co-founder of Sirtris) by Charlie Rose can be found

Sirtris drug may fight diseases of age - The Boston Globe
Scientists at Sirtris Pharmaceuticals Inc. of pathology at Harvard Medical School and cofounder of Cambridge-based Sirtris.

Sirtris Tests Fountain of Youth Pill - Science Column - David Ewing
When Spanish explorer Juan Ponce de Leon heard rumors of a fountain of youth from native Floridians in 1513, he was desperate enough to find it that he was willing

Sirtris shares rise on study - Boston.com
Shares of Sirtris Pharmaceuticals Inc. jumped Friday, a day after the company announced publication of a study indicating a new mechanism that could slow aging.

IPOhome - IPO Company Profile for Sirtris Pharmaceuticals (SIRT)
Sirtris Pharmaceuticals increases share count, prices at midpoint. 4/18/07. Biopharmaceutical company Sirtris Pharmaceutical announces terms. 3/1/07

Sirtris and Harvard Unveil Promising, Novel SIRT1 Activators for
Data Published in the Journal Nature Sirtris Identifies Drug Candidates 1,000 Now, scientists at Sirtris have developed SIRT1activating molecules that are

Sirtris Pharmaceuticals, Inc.
Sirtris Pharmaceuticals™ (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the

Sirtris Pharmaceuticals: Resveratrol reduces fat and boosts endurance
Press Releases CAMBRIDGE , MA – March 1 st , 2007 - Sirtris Pharmaceuticals Inc. today announced that it has filed a registration statement with the Securities and Exchange

phx.corporate-ir.net
Sirtris

phx.corporate-ir.net
Sirtris Pharmaceuticals Presents Results Of Studies Of Sirt1 Activators Sirtris Investor Relations News Release

Sirtris Pharmaceuticals' SRT501 Slows Retinal Ganglion Cell Loss
Sirtris Pharmaceuticals is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat

Sirtris Pharmaceuticals Enters Collaborative Study Testing New
Sirtris Pharmaceuticals (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced that it will

Sirtris Retains NCI to Evaluate Anticancer Agents
Sirtris Pharmaceuticals will collaborate with the NCI to test its SIRT1 enzyme activators in different cancer models. The research will include SRT501, a formulation of the

SIRT: Summary for SIRTRIS PHARMA INC. - Yahoo! Finance
Get detailed information on SIRTRIS PHARMA INC. (SIRT) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest company

SIRT: Summary for SIRTRIS PHARMA INC. - Yahoo! Finance
Get detailed information on SIRTRIS PHARMA INC. (SIRT) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest company

Sirtris Pharmaceuticals, Inc. Company Profile - View Sirtris
Sign-up Now for a Free Test Drive of a New Sales Prospecting and Leads subscription services. About Sirtris Pharmaceuticals, Inc. Sirtris Pharmaceuticals (NASDAQ: SIRT) is a